COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB IN GASTROINTESTINAL STROMAL TUMOURS IN ENGLAND USING CROSSOVER ADJUSTMENT METHODS

被引：0
|
作者：
Pitcher, A. [1 ]
Grabbi, E. [2 ]
Madin-Warburton, M. [1 ]
Vadgama, S. [1 ]
机构：
[1] IMS Hlth, London, England
[2] Bayer Pharmaceut, Newbury, Berks, England
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2255
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN182
引用
收藏
页码：A741 / A741
页数：1
相关论文
共 50 条
  • [41] A COST-EFFECTIVENESS ANALYSIS OF THREE YEARS OF ADJUVANT IMATINIB IN KIT plus GASTROINTESTINAL STROMAL TUMORS (GIST) IN GREECE
    Raikou, M.
    Boukovinas, I.
    Geitona, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 236 - 236
  • [42] COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB AND TAS-102 IN REFRACTORY METASTATIC COLORECTAL CANCER
    Cho, S. K.
    Hay, J. W.
    Barzi, A.
    VALUE IN HEALTH, 2018, 21 : S1 - S1
  • [43] Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations
    Nixon, RM
    Thompson, SG
    HEALTH ECONOMICS, 2005, 14 (12) : 1217 - 1229
  • [44] SURVIVAL CROSSOVER ADJUSTMENT AND COST EFFECTIVENESS ANALYSIS: AN EMPIRICAL AND METHODOLOGICAL REVIEW WITH APPLICATION
    Hopkins, R. B.
    Campbell, K.
    Burke, N.
    Levine, M.
    Thabane, L.
    Duong, M.
    Shum, D.
    Goeree, R.
    VALUE IN HEALTH, 2014, 17 (03) : A202 - A202
  • [45] Bayesian cost-effectiveness analysis: Illustration of methods.
    Fryback, DG
    Chinnis, JO
    Uvila, J
    MEDICAL DECISION MAKING, 1998, 18 (04) : 484 - 484
  • [46] METHODS OF COST-EFFECTIVENESS ANALYSIS - AREAS OF CONSENSUS AND DEBATE
    LUCE, BR
    SIMPSON, K
    CLINICAL THERAPEUTICS, 1995, 17 (01) : 109 - 125
  • [47] Regression methods for cost-effectiveness analysis with censored data
    Willan, AR
    Lin, DY
    Manca, A
    STATISTICS IN MEDICINE, 2005, 24 (01) : 131 - 145
  • [48] Cost-Effectiveness Analysis of Selected Methods of Haemostatis Evaluation
    Zavadil, Martin
    Blahynkova, Michaela
    Selcan, Miroslav
    Rogalewicz, Vladimir
    XV MEDITERRANEAN CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING AND COMPUTING - MEDICON 2019, 2020, 76 : 1085 - 1090
  • [49] Bayesian methods for evidence synthesis in cost-effectiveness analysis
    A. E. Ades
    Mark Sculpher
    Alex Sutton
    Keith Abrams
    Nicola Cooper
    Nicky Welton
    Guobing Lu
    PharmacoEconomics, 2006, 24 : 1 - 19
  • [50] Bayesian methods for evidence synthesis in cost-effectiveness analysis
    Ades, AE
    Sculpher, M
    Sutton, A
    Abrams, K
    Cooper, N
    Welton, N
    Lu, GB
    PHARMACOECONOMICS, 2006, 24 (01) : 1 - 19
12345